Israel Neuroprotective Agents Market (2025-2031) | Trends, Competitive Landscape, Analysis, Size & Revenue, Outlook, Share, Forecast, Value, Industry, Segmentation, Companies, Growth

Market Forecast By Drug Class (Anesthetics, Antagonists, Antidepressants, Cytokines, Others), By Application (Alzheimer's disease, Dementia, Epilepsy, Multiple sclerosis, Others), By Route of Administration (Oral, Topical, Epidural, Intravenous), By Distribution Cahnnel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) And Competitive Landscape
Product Code: ETC7656989 Publication Date: Sep 2024 Updated Date: Oct 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Israel Neuroprotective Agents Market Top 5 Importing Countries and Market Competition (HHI) Analysis

In 2024, Israel saw continued imports of neuroprotective agents from top exporters including Switzerland, UK, Belgium, USA, and Germany. The market displayed low concentration with a low Herfindahl-Hirschman Index (HHI). Despite a slight decline in the Compound Annual Growth Rate (CAGR) from 2020-2024 at -2.14%, the sector remained relatively stable with a marginal decrease in growth rate from 2023-2024 at -0.41%. The consistent flow of imports from diverse sources indicates a steady demand for neuroprotective agents in Israel.

Key Highlights of the Report:

  • Israel Neuroprotective Agents Market Outlook
  • Market Size of Israel Neuroprotective Agents Market, 2024
  • Forecast of Israel Neuroprotective Agents Market, 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Revenues & Volume for the Period 2021- 2031
  • Israel Neuroprotective Agents Market Trend Evolution
  • Israel Neuroprotective Agents Market Drivers and Challenges
  • Israel Neuroprotective Agents Price Trends
  • Israel Neuroprotective Agents Porter's Five Forces
  • Israel Neuroprotective Agents Industry Life Cycle
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Drug Class for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Anesthetics for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Antagonists for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Antidepressants for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Cytokines for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Alzheimer's disease for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Dementia for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Epilepsy for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Multiple sclerosis for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Topical for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Epidural for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Intravenous for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Distribution Cahnnel for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Drug Stores for the Period 2021- 2031
  • Historical Data and Forecast of Israel Neuroprotective Agents Market Revenues & Volume By Online Pharmacies for the Period 2021- 2031
  • Israel Neuroprotective Agents Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Distribution Cahnnel
  • Israel Neuroprotective Agents Top Companies Market Share
  • Israel Neuroprotective Agents Competitive Benchmarking By Technical and Operational Parameters
  • Israel Neuroprotective Agents Company Profiles
  • Israel Neuroprotective Agents Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Israel Neuroprotective Agents Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Israel Neuroprotective Agents Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Israel Neuroprotective Agents Market Overview

3.1 Israel Country Macro Economic Indicators

3.2 Israel Neuroprotective Agents Market Revenues & Volume, 2021 & 2031F

3.3 Israel Neuroprotective Agents Market - Industry Life Cycle

3.4 Israel Neuroprotective Agents Market - Porter's Five Forces

3.5 Israel Neuroprotective Agents Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 Israel Neuroprotective Agents Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 Israel Neuroprotective Agents Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Israel Neuroprotective Agents Market Revenues & Volume Share, By Distribution Cahnnel, 2021 & 2031F

4 Israel Neuroprotective Agents Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurological disorders in Israel

4.2.2 Growing awareness about the benefits of neuroprotective agents in preventing neurodegenerative diseases

4.2.3 Advancements in medical technology and research leading to the development of innovative neuroprotective agents

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of neuroprotective agents in Israel

4.3.2 High cost associated with neuroprotective agents leading to limited affordability for some patients

4.3.3 Potential side effects and safety concerns associated with neuroprotective agents

5 Israel Neuroprotective Agents Market Trends

6 Israel Neuroprotective Agents Market, By Types

6.1 Israel Neuroprotective Agents Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 Israel Neuroprotective Agents Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 Israel Neuroprotective Agents Market Revenues & Volume, By Anesthetics, 2021- 2031F

6.1.4 Israel Neuroprotective Agents Market Revenues & Volume, By Antagonists, 2021- 2031F

6.1.5 Israel Neuroprotective Agents Market Revenues & Volume, By Antidepressants, 2021- 2031F

6.1.6 Israel Neuroprotective Agents Market Revenues & Volume, By Cytokines, 2021- 2031F

6.1.7 Israel Neuroprotective Agents Market Revenues & Volume, By Others, 2021- 2031F

6.2 Israel Neuroprotective Agents Market, By Application

6.2.1 Overview and Analysis

6.2.2 Israel Neuroprotective Agents Market Revenues & Volume, By Alzheimer's disease, 2021- 2031F

6.2.3 Israel Neuroprotective Agents Market Revenues & Volume, By Dementia, 2021- 2031F

6.2.4 Israel Neuroprotective Agents Market Revenues & Volume, By Epilepsy, 2021- 2031F

6.2.5 Israel Neuroprotective Agents Market Revenues & Volume, By Multiple sclerosis, 2021- 2031F

6.2.6 Israel Neuroprotective Agents Market Revenues & Volume, By Others, 2021- 2031F

6.3 Israel Neuroprotective Agents Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Israel Neuroprotective Agents Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Israel Neuroprotective Agents Market Revenues & Volume, By Topical, 2021- 2031F

6.3.4 Israel Neuroprotective Agents Market Revenues & Volume, By Epidural, 2021- 2031F

6.3.5 Israel Neuroprotective Agents Market Revenues & Volume, By Intravenous, 2021- 2031F

6.4 Israel Neuroprotective Agents Market, By Distribution Cahnnel

6.4.1 Overview and Analysis

6.4.2 Israel Neuroprotective Agents Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 Israel Neuroprotective Agents Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.4 Israel Neuroprotective Agents Market Revenues & Volume, By Drug Stores, 2021- 2031F

6.4.5 Israel Neuroprotective Agents Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

7 Israel Neuroprotective Agents Market Import-Export Trade Statistics

7.1 Israel Neuroprotective Agents Market Export to Major Countries

7.2 Israel Neuroprotective Agents Market Imports from Major Countries

8 Israel Neuroprotective Agents Market Key Performance Indicators

8.1 Research and development investment in neuroprotective agents

8.2 Number of clinical trials conducted for neuroprotective agents in Israel

8.3 Adoption rate of neuroprotective agents by healthcare professionals in Israel

8.4 Patient adherence and compliance to neuroprotective agent treatment regimens

9 Israel Neuroprotective Agents Market - Opportunity Assessment

9.1 Israel Neuroprotective Agents Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 Israel Neuroprotective Agents Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 Israel Neuroprotective Agents Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Israel Neuroprotective Agents Market Opportunity Assessment, By Distribution Cahnnel, 2021 & 2031F

10 Israel Neuroprotective Agents Market - Competitive Landscape

10.1 Israel Neuroprotective Agents Market Revenue Share, By Companies, 2024

10.2 Israel Neuroprotective Agents Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All